Protection Against Acute, Ascending Pyelonephritis Caused by Escherichia Coli in Rats, Using Isolated Capsular Antigen Conjugated to Bovine Serum Albumin
Overview
Authors
Affiliations
We found that isolated Escherichia coli K13 antigen conjugated to bovine serum albumin, in contrast to isolated, non-conjugated K13, was highly immunogenic and induced protection against acute pyelonephritis caused by E. coli O6K13H1 in rats.
Vaccines against extraintestinal pathogenic (ExPEC): progress and challenges.
Qiu L, Chirman D, Clark J, Xing Y, Hernandez Santos H, Vaughan E Gut Microbes. 2024; 16(1):2359691.
PMID: 38825856 PMC: 11152113. DOI: 10.1080/19490976.2024.2359691.
Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.
Loubet P, Ranfaing J, Dinh A, Dunyach-Remy C, Bernard L, Bruyere F Front Microbiol. 2020; 11:1509.
PMID: 32719668 PMC: 7350282. DOI: 10.3389/fmicb.2020.01509.
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.
OBrien V, Hannan T, Nielsen H, Hultgren S Microbiol Spectr. 2016; 4(1).
PMID: 26999391 PMC: 4887100. DOI: 10.1128/microbiolspec.UTI-0013-2012.
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.
Brumbaugh A, Mobley H Expert Rev Vaccines. 2012; 11(6):663-76.
PMID: 22873125 PMC: 3498450. DOI: 10.1586/erv.12.36.
Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.
Johnson J, Gajewski A, Lesse A, Russo T J Clin Microbiol. 2003; 41(12):5798-802.
PMID: 14662987 PMC: 309005. DOI: 10.1128/JCM.41.12.5798-5802.2003.